How can a train run fast?
Release time:
2020-08-14
How can a train run fast?
There is an old saying that "a train runs fast, all by the headband", and many people still have memories in their minds of the deafening roar of a locomotive with a chimney on its roof. But now, fewer and fewer people say this sentence. Because of the popularity of high-speed trains and high-speed trains, it is more and more convenient for Chinese people to travel. While relying on the headband, EMUs generally adopt power dispersion technology. Each carriage has a power device, which ensures the fast and stable operation of the train. Of course, its driving speed is incomparable to the traditional "headband with carriage" type old trains.
The old saying at the beginning of this article used to be used to guide business management-with good leaders, companies can keep moving forward. But in China, where economic development has already taken the bullet train, can enterprises expect to "run fast" and "rely on the headband"?
In traditional enterprise management, the leader is the "head", responsible for making decisions, and the employee is the "carriage", responsible for doing things according to the leader's instructions, and is the "labor". The leadership plays a decisive role in how fast and how far an enterprise can run. Of course, being able to become a person in charge of an enterprise should be more prominent in the team in terms of knowledge structure, ideas, strategic decision-making, etc., but there is an old saying called "a wise man must lose everything", especially in the current knowledge update In the fast-changing environment of the market, a person's ability is very limited, even if his "motivation" is very strong, he must drag a team and a group of people forward together, it is also inevitable that we will not be able to do what we want. In the new historical era, we have chosen high-speed trains, and the old-fashioned front-powered trains have gradually become history; and if enterprises cannot "run fast", they are bound to be eliminated by the market. The front of
EMU has power, but the more important thing is to set the direction. The key to running fast is that the carriages unite and run forward together. And if our company wants to become a moving car, it cannot completely rely on the "front", and cannot be satisfied with being dragged by the "front" passively. Instead, it should take the initiative along the direction determined by the "front" with its companions. Go forward.
EMU runs fast, which is not only a change in appearance, structure, and working methods, but also requires each car to have the ability to provide power for the overall speed increase. A car with aging parts, defects, or power equipment that cannot operate, or without sufficient energy, cannot be incorporated into the car group for online operation. The same is true in enterprises. The knowledge and skill structure cannot keep up with the needs of the post, those who are unwilling to use their brains, do not want to pay, and lack work initiative. In the process of continuous reform, adjustment and optimization of the enterprise, they will inevitably be gradually marginalized, and finally usher in the result of being eliminated. As an employee, to avoid this result, you need to continue to learn, study, and constantly recharge yourself, so that you can keep up with the pace of enterprise development, and even provide impetus for enterprise development.
"The bullet train runs fast, everyone comes together", this is the train operation mode of the new era. As far as enterprises are concerned, it should be the same as the operation and management of enterprises and the specific work of workshops and teams. (Hongtao)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31